IP LICENSING AND MUTUAL EXCLUSIVITY AGREEMENT ("IP and Mutual Exclusivity Agreement")Ip Licensing and Mutual Exclusivity Agreement • December 19th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • British Columbia
A letter of intent was concluded between the Parties on August 1, 2024 and the parties have now agreed to conclude this bundle of agreements ("Bundle of Agreements") comprising:
